cover
Contact Name
Dewi Yuniasih
Contact Email
dewi.yuniasih@med.uad.ac.id
Phone
+62274563515
Journal Mail Official
uad.admj@gmail.com
Editorial Address
Jl. Universitas Ahmad Dahlan Kampus 4, Kragilan, Tamanan, Kec. Banguntapan, Kabupaten Bantul, Daerah Istimewa Yogyakarta 55191
Location
Kota yogyakarta,
Daerah istimewa yogyakarta
INDONESIA
Ahmad Dahlan Medical Journal
ISSN : -     EISSN : 27743837     DOI : 10.12928/admj
Core Subject : Health, Science,
Ahmad Dahlan Medical Journal is a peer-reviewed and open access journal that focuses on promoting medical sciences generated from basic sciences, clinical, and community or public health research to integrate researches in all aspects of human health. This journal publishes original articles, reviews, and also interesting case reports. Brief communications containing short features of medicine, latest developments in diagnostic procedures, treatment, or other health issues that is important for the development of health care system are also acceptable. Letters and commentaries of our published articles are welcome. Subjects suitable for publication include, but are not limited to the following fields of Allergy and immunology, Anesthesiology, Cancer and stem cells, Cardiovascular, Cell and molecular biology, Child health, Dermato-venereology, Geriatrics, Histopathology, Internal medicine, Neuro-psychiatric medicine, Ophthalmology, Oral medicine, Otorhynolaryngology, Physical medicine and rehabilitation, Physio-pharmacology, Pulmonology, Radiology, Surgery including orthopedic and urology, and Women’s health.
Articles 111 Documents
A Consultation-Liaison Psychiatry Approach to Anxiety in a Patient with Multidrug-Resistant Tuberculosis: Case Report Hapsari, Septika Purnastuti; Nugroho, Nur Prasetyo; Rahmawati, Novi Agung
Ahmad Dahlan Medical Journal Vol. 7 No. 1 (2026): May 2026
Publisher : Universitas Ahmad Dahlan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.12928/admj.v7i1.15977

Abstract

The interplay of social stigma, the grueling duration of treatment, and residual drug toxicities frequently triggers psychiatric comorbidities in multidrug-resistant TB (MDR-TB), which can severely compromise treatment adherence. We reported a 24-year-old female MDR-TB patient presented with escalating insomnia and severe anxiety. Her psychological distress followed the onset of physical complications three months prior, including peripheral paresthesia (tingling) and impaired mobility. These physical symptoms exacerbated her breathlessness and sleep disturbances. Following a referral to the psychiatry department, a Consultation-Liaison Psychiatry (CLP) framework was initiated. Through integrated psychiatric intervention and pharmacological dose adjustment for her MDR-TB regimen, the patient’s anxiety significantly diminished, and her physical side effects became manageable. The following evaluation of MDR-TB, both clinically and radiologically, showed improvement. The patient declared cured after a six-month duration of MDR-TB treatment. CLP provides a vital bridge in specialized care, addressing the depression, anxiety, and psychosis that often act as barriers to successful MDR-TB recovery.

Page 12 of 12 | Total Record : 111